Updated on 14 June 2016
Singapore: Korea's leading CRO, LSK Global has expanded its use of Medidata Clinical cloud platform, thus strengthening its global R&D capabilities. The Seoul based organization was established in 2000, and is a full-service CRO specializing in a number of therapeutic areas-including oncology, cardiovascular and endocrinology.
Mr Young Jack Lee, President, LSK Global PS, said, "We are dedicated to advancing the quality of our domestic clinical trials to that of a global standard, and Medidata's robust, globally-validated CTMS is helping us reach that standard. Medidata CTMS enables us to conduct more efficient clinical research, accelerating study timelines and reducing development costs while ensuring the highest quality. We're excited to take our drug development program to the next level by using more technology solutions on Medidata's industry-leading, unified cloud platform to manage clinical trials across therapeutic areas."
LSK Global conducts hundreds of clinical trial programs on both a local and global scale. The company also conducts Phase I-Phase IV studies, investigator initiated trials, post-market surveillance (PMS), and observational research, and provides data management services for its life sciences customers.
"We are pleased to strengthen our partnership with LSK Global," said Mr Edwin Ng, Medidata's vice president of field operations, APeJ (Asia Pacific except Japan). South Korea is evolving as a key market in Asia's expanding clinical trial landscape and by leveraging CTMS' customized reporting capabilities LSK Global PS is able to extract the operational data it needs to effectively deploy critical resources, proactively address performance issues and streamline study workflows. We look forward to our ongoing collaboration with LSK, providing its research teams with the technology needed to accelerate medical innovation across the region and beyond."
LSK Global PS has been utilizing Medidata's electronic data capture, management and reporting tool (Medidata Rave), medical coding solution (Medidata Coder), and unified randomization and trial supply management solution (Medidata Balance). To provide better oversight into trial operations and streamline its site monitoring processes, the CRO is now adopting Medidata's clinical trial management system, Medidata CTMS.